Details
Stereochemistry | ACHIRAL |
Molecular Formula | C20H24N2OS |
Molecular Weight | 340.482 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(=O)C1=CC2=C(SC3=C(C=CC=C3)N2CCCN(C)C)C=C1
InChI
InChIKey=ZQTVCQIJTREKSP-UHFFFAOYSA-N
InChI=1S/C20H24N2OS/c1-4-18(23)15-10-11-20-17(14-15)22(13-7-12-21(2)3)16-8-5-6-9-19(16)24-20/h5-6,8-11,14H,4,7,12-13H2,1-3H3
Molecular Formula | C20H24N2OS |
Molecular Weight | 340.482 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Propionylpromazine is used as a neuroleptic to combat stress in pets and farm animals. The main use is to combat stress in the transport of pigs. Propionylpromazine was in common use in veterinary practice in the 1950s and 1960s. Propionylpromazine is of interest to JECFA because of the illicit use at pharmacological dosage (< 1 mg/kg i.m.) in the immediate pre-slaughter period.
CNS Activity
Sources: http://www.sigmaaldrich.com/catalog/product/sigma/p7780?lang=en®ion=RUhttp://www.fao.org/fileadmin/user_upload/vetdrug/docs/41-4-propionylpromazine.pdf
Curator's Comment: D2 dopamine receptor antagonist; phenothiazine antipsychotic.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL5131 |
|||
Target ID: CHEMBL5131 |
357.0 µM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Propiopromazine Approved UseIndications for use. For oral administration as a tranquilizer. As an aid in handling difficult, excited, and unruly dogs, and in controlling excessive kennel barking, car sickness, and severe dermatitis. It is also indicated for use in minor surgery and prior to routine examinations, laboratory procedures, and diagnostic procedures. |
|||
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1078293 |
Primary | TRANVET Approved UsePropionylpromazine is used as a neuroleptic to combat stress in pets and farm animals. The main use is to combat stress in the transport of pigs. Launch Date-2.95920009E11 |
PubMed
Title | Date | PubMed |
---|---|---|
Effects of electroanesthesia and a phenothiazine tranquilizer on thermoregulation in the sheep. | 1977 Mar |
|
[Inactivation of Trypanosoma cruzi trypanothione reductase by phenothiazine cationic free radicals]. | 2001 Jan-Mar |
|
Development of a rapid screening test for veterinary sedatives and the beta-blocker carazolol in porcine kidney by ELISA. | 2004 Feb |
|
Comprehensive screening and quantification of veterinary drugs in milk using UPLC-ToF-MS. | 2008 Jul |
|
Effects of inosine on reperfusion injury after cardiopulmonary bypass. | 2010 Nov 8 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.law.cornell.edu/cfr/text/21/520.2002
Dogs: Administer 0.5 to 2.0 milligrams per pound of body weight once or twice daily, depending upon the degree of tranquilization desired.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11407019
10 uM Propiopromazine produced 95-100% inactivation of Trypanosoma cruzi trypanothione reductase (TR).
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:20:02 UTC 2023
by
admin
on
Fri Dec 15 16:20:02 UTC 2023
|
Record UNII |
Y1BCT334I7
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29710
Created by
admin on Fri Dec 15 16:20:02 UTC 2023 , Edited by admin on Fri Dec 15 16:20:02 UTC 2023
|
||
|
CFR |
21 CFR 520.2002
Created by
admin on Fri Dec 15 16:20:02 UTC 2023 , Edited by admin on Fri Dec 15 16:20:02 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3568-24-9
Created by
admin on Fri Dec 15 16:20:02 UTC 2023 , Edited by admin on Fri Dec 15 16:20:02 UTC 2023
|
PRIMARY | |||
|
300000031240
Created by
admin on Fri Dec 15 16:20:02 UTC 2023 , Edited by admin on Fri Dec 15 16:20:02 UTC 2023
|
PRIMARY | |||
|
C026328
Created by
admin on Fri Dec 15 16:20:02 UTC 2023 , Edited by admin on Fri Dec 15 16:20:02 UTC 2023
|
PRIMARY | |||
|
DTXSID3046950
Created by
admin on Fri Dec 15 16:20:02 UTC 2023 , Edited by admin on Fri Dec 15 16:20:02 UTC 2023
|
PRIMARY | |||
|
24352
Created by
admin on Fri Dec 15 16:20:02 UTC 2023 , Edited by admin on Fri Dec 15 16:20:02 UTC 2023
|
PRIMARY | |||
|
DB11540
Created by
admin on Fri Dec 15 16:20:02 UTC 2023 , Edited by admin on Fri Dec 15 16:20:02 UTC 2023
|
PRIMARY | |||
|
m9213
Created by
admin on Fri Dec 15 16:20:02 UTC 2023 , Edited by admin on Fri Dec 15 16:20:02 UTC 2023
|
PRIMARY | Merck Index | ||
|
222-662-1
Created by
admin on Fri Dec 15 16:20:02 UTC 2023 , Edited by admin on Fri Dec 15 16:20:02 UTC 2023
|
PRIMARY | |||
|
Y1BCT334I7
Created by
admin on Fri Dec 15 16:20:02 UTC 2023 , Edited by admin on Fri Dec 15 16:20:02 UTC 2023
|
PRIMARY | |||
|
C84113
Created by
admin on Fri Dec 15 16:20:02 UTC 2023 , Edited by admin on Fri Dec 15 16:20:02 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |